- Springer Nature
- Nature Research Staff Members
- United Kingdom
About Ben Johnson
I gained my first degree in virology from the University of Warwick and a PhD in influenza virus immune evasion from Public Health England and the University of Reading, UK. My research interests then moved on to smallpox vaccines, viral ion channels, and cell adhesion, while a postdoc at Imperial College London. I joined open access publisher BioMed Central in 2011 as an Acquisitions Editor and then Associate Publisher, and was responsible for launching new journals, including Microbiome, Zoological Letters, and Movement Ecology. I have been Head of Communities & Engagement at Springer Nature since 2016, running our online community blogs, and a Consulting Editor at Nature Medicine since June 2020, handling COVID-19 papers. I am based in our London office.
Recent Comments
Hi Victoria, thanks for your comment and sorry to hear you are unwell. We don't give any medical advice to individuals through this community, you will have to contact your local health professi...
This is good to hear, thanks Alicia. I will continue writing this as long as it is useful, or until the volume of papers overwhelms me!
There's a great article in the New York Times on the challenge of counting deaths from COVID-19, where they measure excess deaths https://www.nytimes.com/interactive/2020/04/21/world/coronavirus...
It's great to see so much discussion on this post.
Please keep your comments respectful. Any comments in violation of our community policy will be deleted and the users blocked from commen...
This comment was highly inappropriate and clearly broke our community policy. It has been deleted.
Thanks for this excellent analysis! A friend shared the original study with me, and my response was similar to yours, but I have now shared your much more detailed response with them. I would al...
Thank you for the correction! I personally wish that the same name had been given to the virus and the disease, but do understand the logic of SARS-CoV-2 as a name.
I don't. I would expect that some doctors will add Azithromycin too, and as long as they record that in the data sent to WHO, it should still be useful.